Search research articles
Contact Us
Filters
Showing results (81-90 of 89) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 89 results.
Mechanisms of Ageing and Development
|
March 1, 1997
HLA and longevity or aging among Shanghai Chinese
Y X Ma, Y Zhu, Z S Wang, et al.
Oncogene
|
March 13, 2001
Role of direct interaction in BRCA1 inhibition of estrogen receptor activity
S Fan, Y X Ma, C Wang, et al.
Science Robotics
|
November 2, 2020
AADS: Augmented autonomous driving simulation using data-driven algorithms
W Li, C W Pan, R Zhang, et al.
Science Advances
|
April 17, 2019
Contribution of biomimetic collagen-ligand interaction to intrafibrillar mineralization
Q Song, K Jiao, L Tonggu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 11, 2013
Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma
X Wu, P Y Huang, P J Peng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 23, 2012
Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma
C Xue, Y Huang, P Y Huang, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
January 19, 2025
[Distribution characteristics and heritability of alcohol consumption behavior in adult twins in China]
Y C Li, W J Gao, W H Cao, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
December 21, 2021
[Twelve-week of sofosbuvir/velpatasvir therapeutic regimen for chronic hepatitis C patients in northwest region of China: a real-world multicenter clinical study]
Q Xu, W Zhang, Y X Ma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2026
Izalontamab brengitecan (Iza-bren; BL-B01D1), a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, for patients with EGFR-mutated NSCLC: Pooled analysis of phase 1 and phase 2 trials
S-D Hong, Y-S Wang, H-Y Zhao, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 89) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 89 results.
Mechanisms of Ageing and Development
|
March 1, 1997
HLA and longevity or aging among Shanghai Chinese
Y X Ma, Y Zhu, Z S Wang, et al.
Oncogene
|
March 13, 2001
Role of direct interaction in BRCA1 inhibition of estrogen receptor activity
S Fan, Y X Ma, C Wang, et al.
Science Robotics
|
November 2, 2020
AADS: Augmented autonomous driving simulation using data-driven algorithms
W Li, C W Pan, R Zhang, et al.
Science Advances
|
April 17, 2019
Contribution of biomimetic collagen-ligand interaction to intrafibrillar mineralization
Q Song, K Jiao, L Tonggu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 11, 2013
Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma
X Wu, P Y Huang, P J Peng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 23, 2012
Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma
C Xue, Y Huang, P Y Huang, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
January 19, 2025
[Distribution characteristics and heritability of alcohol consumption behavior in adult twins in China]
Y C Li, W J Gao, W H Cao, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
December 21, 2021
[Twelve-week of sofosbuvir/velpatasvir therapeutic regimen for chronic hepatitis C patients in northwest region of China: a real-world multicenter clinical study]
Q Xu, W Zhang, Y X Ma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2026
Izalontamab brengitecan (Iza-bren; BL-B01D1), a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, for patients with EGFR-mutated NSCLC: Pooled analysis of phase 1 and phase 2 trials
S-D Hong, Y-S Wang, H-Y Zhao, et al.
Page
of 9